Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
CA19-9 Levels in Saliva and Urine of Patients with Ductal Adenocarcinoma of the Pancreas Correlates with Serum CA19-9 Levels - A Prospective Preliminary Study
Performance of triple-marker panel vs. CA19-9 | Download Table
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
CA19-9 Level to Serum γ-Glutamyltransferase as a Potential Progn | CMAR
Evaluation of CEA, CA19-9, CRP and leucocyte count as prognostic marker... | Download Scientific Diagram
CA 19-9 – Pancreatic Cancer Action Network
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer -
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
Diseases | Free Full-Text | Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer | HTML
Cureus | Low Carbohydrate Antigen 19-9 (CA 19-9) Levels in a Patient Highly Suspected of Having Caput Pancreas Tumor
Molecules | Free Full-Text | Electrochemical Immunoassay for Tumor Marker CA19-9 Detection Based on Self-Assembled Monolayer
The prognostic and predictive value of serum CA19.9 in pancreatic cancer - Annals of Oncology
CA19.9 Test : Results, procedures, purpose, & risks - FactDr
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection - Gastroenterology
extreme High levels of ca19-9 associated with adenocarcinoma of the lung
Comparison of two immunoassays for CA19-9, CEA and AFP tumor markers - Biochemia Medica
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection - Gastroenterology